C66 - Taxane-rechallenge in HER2-positive breast cancer patients who develop an oligo-progression during pertuzumab-trastuzumab maintenance therapy
- Resource Type
- Article
- Source
- In
Annals of Oncology October 2017 28 Supplement 6:vi43-vi43 - Subject
- Language
- ISSN
- 0923-7534